Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes | Zendy

Stefan Kiechl | Zendy; Johann Willeit | Zendy; Manuel Mayr | Zendy; Brigitte Viehweider | Zendy; Martin Oberhollenzer | Zendy; Florian Kronenberg | Zendy; Christian J. Wiedermann | Zendy; Sabine Oberthaler | Zendy; Qingbo Xu | Zendy; Joseph L. Witztum | Zendy; Sotirios Tsimikas | Zendy

Open Access

Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes

Author(s) -

Stefan Kiechl,

Johann Willeit,

Manuel Mayr,

Brigitte Viehweider,

Martin Oberhollenzer,

Florian Kronenberg,

Christian J. Wiedermann,

Sabine Oberthaler,

Qingbo Xu,

Joseph L. Witztum,

Sotirios Tsimikas

Publication year - 2007

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.107.145805

Subject(s) - lipoprotein associated phospholipase a2 , apolipoprotein b , lipoprotein(a) , medicine , hazard ratio , lipoprotein , myocardial infarction , population , c reactive protein , endocrinology , cardiology , cholesterol , confidence interval , inflammation , environmental health

Oxidized phospholipids (OxPL) circulate on apolipoprotein B-100 particles (OxPL/apoB), and primarily on Lp(a) lipoprotein (a) [Lp(a)]. The relationship of OxPL/apoB levels to future cardiovascular events is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research